Introduction
Our population is aging, but longevity is not always associated with good health and an increasing number of our older population are burdened with frailty, ill-health and functional limitation (Parker and Thorslund, 2007) . There has been a substantial rise in the prevalence of chronic, non-communicable diseases associated with age (World Health Organisation, 2017) . For example, the prevalence of cardiovascular disease (including hypertension, coronary heart disease and heart failure) increases from 40% in people aged 40-59 years of age (Mannino et al., 2008) to 70% in people aged 70 years of age (LloydJones et al., 2009 ); Chronic Obstructive Pulmonary Disease (COPD) increases from 8% in adults aged 50 to 20% of adults aged 70 (Hanania and Sharma, 2010) . Furthermore, it is increasingly common for an older person to suffer with a number of medical conditions. Multi-morbidity (defined as two or more chronic diseases in one person (Barnett et al., 2012) ) affects approximately 65% of over 60 year olds, of which 80% live with disabilities (Barnett et al., 2012) and multi-morbidity accounts for 60% of global deaths (Rizzuto et al., 2017) . The World Health Organisation has recognized this burden of ill-health (increased lifespan with multi-morbidity) as a major challenge to be faced by global health care systems (World Health Organization, 2016) , and in 2016, the first multi-morbidity care guidelines were published (NIfHaC Excellence, 2016) , although the evidence base for multi-morbid health care pathways is limited.
The most common chronic non-communicable diseases are associated with inflammation, for example, COPD (Stone et al., 2012) , type 2 diabetes (Ayilavarapu et al., 2010) , osteoporosis and dementia (Bruunsgaard et al., 1999) and these conditions often cooccur. Recent studies have demonstrated patterns of disease clustering (Jackson et al., 2015) , with links seen between cardiovascular disease risk factors and conditions, metabolic conditions, and pain, musculoskeletal and psychological conditions (Déruaz-Luyet et al., 2017) . Many of these conditions share risk factors of age, cigarette smoking, lower socioeconomic group, and sedentary lifestyle but the odds ratio of them occurring together are greater than would be predicted once these common shared risk factors are taken into account (Mannino et al., 2008; Sevenoaks and Stockley, 2006) . As well as chronic illness, there is a significant burden of infection related mortality and morbidity in our aging population. Pneumonia (a severe lung infection defined by symptoms of a lower respiratory tract infection and new consolidative changes on a chest radiograph (Lim et al., 2003) ) remains the commonest form of infectious death in the developed world, the fifth leading cause of death worldwide. Pneumonia is diagnosed in approximately 10.6 per 1000 person years (Broulette et al., 2013) but 75 per 1000 person years in adults aged over 70 (Fein, 1999) . Deaths are highest in old patients, with mortality rates not improved over the last decade (Lindenauer et al., 2012; Klevens et al., 2008) . Far from being an acute infection, many who survive the initial episode are frailer and require more social support than they did prior to admission (Restrepo et al., 2013; Dick et al., 2012) . Recovery from the primary infection is also associated with an increased risk of secondary infections, and the outcomes from these events is even less certain (van Vught et al., 2016) .
Acute bacterial infections such as pneumonia require a functional immune system, and in particular, a coordinated and controlled innate immune response to clear infection without causing excessive host tissue damage; with the neutrophil being a key effector cell. These cells have been implicated also in the pathogenesis of many of the co-morbidities present in old age. For example, neutrophils are associated with lung tissue destruction in COPD (as reviewed in (Stockley et al., 2013) ) but are also implicated in myocardial infarction (de Boer et al., 2013) , and type 2 diabetes (Alba-Loureiro et al., 2007) and in more general features of ill health in old age, including frailty (Wilson et al., 2017) .
Classical neutrophil functions
Neutrophils comprise 70% of circulating white blood cells, but have a short lifespan (approximately a half-life of 8 h) necessitating a high daily production rate of 1-2 × 10 11 cells/day in health (Amulic et al., 2012; Galli et al., 2011; Borregaard, 2010) . Defined as granulocytes and phagocytes, neutrophils contain a specialized antimicrobial granule system and ingest target particles such as bacteria (Amulic et al., 2012; Faurschou and Borregaard, 2003) . During maturation, neutrophils develop their characteristic granules, which are traditionally divided into three sub-types; azurophilic (primary), specific (secondary) and gelatinase (tertiary). Azurophilic granules contain the neutral serine proteinases, (neutrophil elastase, proteinase 3, and cathepsin G) myeloperoxidase (MPO) and other antimicrobial proteins (e.g. α-defensins) (Faurschou and Borregaard, 2003; Klebanoff, 1999) . Specific (secondary) granules are also predominantly bactericidal and contain products such as lactoferrin (Faurschou and Borregaard, 2003; Cramer et al., 1985; Oram and Reiter, 1968) . Gelatinase (tertiary) granules contain metalloproteases (MMPs) such as gelatinase which digest extracellular matrix and aid neutrophil migration (Amulic et al., 2012; Borregaard and Cowland, 1997) . Neutrophils are also able to generate reactive oxygen species (ROS) by NADPH oxidase, an enzyme which is only activated when its cytosol-based and membrane-based component parts bind, a process stimulated by pathogenic and host-derived inflammatory signals (Segal, 2005) . Degranulation describes mobilization of granules and fusion with the neutrophil membrane, causing release of contents outside the cell or into a phagosomal vacuole (Faurschou and Borregaard, 2003) . When released, granules are both anti-microbial and cytotoxic, and have the potential for significant tissue damage, particularly when they are first released from the neutrophil, as here inhibitors of granule contents (such as Alpha 1 Antitrypsin which inhibits neutrophil elastase) are insufficient in concentration to prevent local protein degradation (Liou and Campbell, 1996) . After release from the bone marrow, neutrophils circulate in systemic blood, displaying high levels of physical plasticity, allowing them to move through capillary networks with diameters half that of the quiescent neurophil by elongating their cell shape, without significant delay in transit times (Summers et al., 2010; Summers et al., 2014) . Towards the end of their short half-life, neutrophils develop an aging phenotype with increased surface expression of CXCR4 (Furze and Rankin, 2008) which is thought to facilitate clearance by apoptosis and subsequent efferocytosis (clearance of neutrophils by phagocytosis) by stromal macrophages.
During an inflammatory or infectious challenge, neutrophils migrate with great accuracy through tissue to sites of infection and inflammation, where they phagocytose bacteria and cell debris. Direction sensing is achieved via occupancy of G-protein coupled receptors (GPCRs) on the surface of the neutrophil, as soluble chemo-attractants (such as Interleukin-8 (CXCL8) or bacterial N-formyl-methionyl-leucylphenylalanine (fMLP)) form gradients, which neutrophils sense by the binding of ligands to receptors at the leading edge of the cell (Raman et al., 2010) . When chemokine's bind their cognate receptors, dissociation of heterotrimeric G proteins activate phosphatidylinositol-3 kinase (PI3K), an enzyme which has been implicated in the regulation of migration (Hannigan and Huang, 2003) , phagocytosis (Botelho et al., 2000) and azurophil degranulation (Ito et al., 2002) . PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP 2 ) to phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ). In health, fluctuations in PIP 3 are associated with the localized formation of pseudopodia (temporary cytoplasm-filled projections from the neutrophil cell membrane), which steer the cytoskeletal rearrangement required to orient the neutrophil to chemo-attractant cues (Yoo et al., 2010) and are required for migration and opsonophagocytosis. There are a number of PI3K classes and isoforms, but Class 1 delta and gamma isoforms are highly expressed in neutrophils, and thought central to accurate migration. Downstream of PI3K, the small GTPases (RhoA, Rac and CDC42) organize cell polarity, motility and phagocytosis with Rac and CDC42 localizing at the leading edge of the cell (Burridge and Doughman, 2006) and RhoA and ROCK driving propulsion at the rear of the cell (Charest and Firtel, 2007) . Migration through the dense extracellular matrix is facilitated by the sequential release of proteinases and reactive oxygen species around the neutrophil (Cepinskas et al., 1999) , degrading a path to assist passage. Thus, the process of migration can be associated with tissue damage.
Phagocytosis is an active, receptor mediated process (Amulic et al., 2012) . In unopsonized phagocytosis, interactions between neutrophilic pattern recognition receptors (PRRs) (such as Toll Like Receptors (Hayashi et al., 2003) ) and surface-expressed pathogen-associated molecular patterns (PAMPs) support slow bacteria envelopment (Amulic et al., 2012) . Opsonized phagocytosis is a much more dynamic process, where neutrophils internalize bacteria through their opsonin receptors, Fc receptors and a sub-group of β2-integrins, which bind complement (Lee et al., 2003) . In the presence of overwhelming infection or during ingestion of large particles, neutrophils display "frustrated phagocytosis" where they degranulate and release proteinases and reactive oxygen species around the semi-internalized particle into the extracellular matrix (Kovari et al., 2016) , causing localized tissue damage. More recently, Neutrophil Extracellular Traps (NETs) have been described, which are large, complex, fibrous structures formed from nuclear chromatin and granular proteins (Brinkmann et al., 2004) which are extruded from neutrophils to ensnare bacteria, bringing them into close association with antimicrobial proteins. These appear to represent a neutrophil's final response to overwhelming infection and inflammation but are also associated with significant local tissue damage (Liu et al., 2016) , caused in part by the effects of proteinases which are more resistant to anti-proteinase inhibition when membrane bound (Owen et al., 1995) . Fig. 1 provides an overview of these functions.
Neutrophils are thought to exist in three states; quiescent, activated or primed (Sapey and Stockley, 2014 ). An activated cell is able to degranulate, produce significant quantities of ROS and release NETs, all of which could harm host tissue. Priming appears to be an intermediate and protective step prior to full activation, from which a cell can step up, and become activated, or step down, and become quiescent, providing a natural break before bactericidal and cytotoxic products are released (Sapey and Stockley, 2014) .
The aging neutrophil
Most of our understanding of the lifespan of a neutrophil is based on murine models.
Circulating neutrophil numbers do not remain constant throughout the day and neutrophils are released and cleared in waves. C-X-C chemokine receptor type 2 (CXCR2) and CXCR4 regulate neutrophil trafficking from the bone marrow. The interaction between CXCR4 and the stromal cell-derived factor 1 (SDF1), also known as C-X-C motif chemokine 12 (CXCL12) retains neutrophils within the marrow environment, while CXCR2 regulates neutrophil mobilization through antagonism of CXCR4 signaling (Eash et al., 2010) . Fresh, young neutrophils are released from the bone marrow during the resting phase of an animal's life (night, for most humans), with absolute neutrophil numbers peaking at this time.
Like all cells in the body, neutrophils age and are susceptible to damage. Aged neutrophils are cleared at the end of the resting phase of the day (Casanova-Acebes et al., 2013) . These oscillations are thought to provide a pool of protective neutrophils at the time when exposure to pathogenic microorganisms is believed to be more likely. Potential damaging triggers are thought to include exposure to external signals (including the microbiota (Zhang et al., 2015) and free radicals), however, unlike monocytes or eosinophils, neutrophils are thought to have little capacity for DNA repair (Salati et al., 2007) . Cellular aging leads to specific changes in the appearance, surface expression and function of neutrophils (reviewed elegantly in (Adrover et al., 2016) ).
In brief, freshly released neutrophils are thought to express high levels of L-selectin (CD62L) on their surface but low levels of CXCR4. Exposure to low grade inflammation increases CD11b/c/ICAM1 and CD49d expression, which in turn promotes migration through the endothelium. Following migration to tissues, cells with low levels of CD47 are more likely to be phagocytosed by tissue macrophages (a process termed efferocytosis). As the cells age, they express more CXCR4, which is the receptor for SDF-1 and consequently, aged neutrophils migrate to areas of high SDF-1 production, including the bone marrow, where they can be cleared following apoptosis (Martin et al., 2003) .
Aging does not always lead to neutrophil clearance however, and during challenges such as sepsis, the redirection of aged neutrophils to bone marrow appears to be suspended. In a recent study, Toll like receptors (TLR-4 in particular) enabled the recruitment of aged neutrophils to an inflammatory focus where the aged cells had an increased capacity to phagocytoze gram-negative and gram-positive bacteria without a corresponding rise in respiratory burst or cytokine production (Uhl et al., 2016) . In contrast, in a different murine model by Zhang et al. reported that aged neutrophils (in response to bacterial products) could produce more NETs and ROS (Zhang et al., 2015) . It remains unclear, therefore whether retaining an aged population of neutrophils is beneficial or potentially damaging, and it is also unclear whether A. Systemic neutrophils adhere and transmigrate past endothelial cells to enter the extracellular matrix. This process is thought to be unaltered with age. B. Once extravasation has taken place, neutrophils follow chemoattractant gradients formed by chemokines to move towards the inflammatory source. They release proteinases and ROS (shown in green) to degrade a pathway through the dense extracellular matrix. In old age, this pathway is less direct, with reduced accuracy of migration. C. Once at the site of infection, neutrophils phagocytoze bacteria into the phagosome, which then matures into a bactericidal lysophagosome (shown in green) by combining the vesicle containing the bacteria with the toxic contents of neutrophil granules. In age, phagocytosis of opsonized bacteria is reduced, with reduced expression of CD16. D. Once the phagocytic capacity of neutrophils has been reached, they extrude their DNA contents which become coated in bactericidal proteins, including neutrophil elastase and myeloperoxidase. NETs can be greater than 10 × larger than the cell itself. In old age, NET release is reduced, thought to be moderated by a reduction in ROS generation, a critical step in NET formation. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Experimental Gerontology 105 (2018) 70-77 these murine responses are present in humans. In reproducing cells, senescence is distinct from being old. Senescence is the process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing cell death, caused by telomere erosion, DNA damage or the aberrant activation of oncogenes. Neutrophils never divide, and therefore it is unclear when, or if, they become senescent, and how one might recognize this state. In other cells, senescence is recognized as a negative and pro-inflammatory condition. Senescent cells secrete various cytokines, chemokines, matrix remodelling proteases and growth factors, a phenotype collectively referred to as the senescence-associated secretory phenotype (SASP) (Muñoz-Espín and Serrano, 2014) . It is unclear, if present, whether neutrophil senescence is a similarly negative process for the host however, in vitro, bench-aged neutrophils demonstrate changes in micro-RNA expression (epigenetic changes) which control chemokine and cytokine signaling, small GTPase activity and regulation of the actin cytoskeleton (Ward et al., 2011) , and these processes are implicated in cell migration, degranulation and inflammation.
Neutrophil heterogeneity
The classical view of neutrophils states these cells have an effective but undifferentiated response to inflammation and significant potential for host injury. However, alongside a recognition that neutrophil functions may change as they age, there is growing recognition that these cells may be more diverse in phenotype than first thought. Neutrophils are transcriptionally active (Yost et al., 2004) , can release a wide array of context specific products (Tecchio et al., 2014) and have an adaptable lifespan depending on activation status and environmental circumstance (Walmsley et al., 2005) . Furthermore, an increasing number of neutrophil phenotypes have been identified in different experimental models, which seem able to display different functional characteristics. During a significant inflammatory challenge such as sepsis, immature neutrophils are released from the bone marrow. These cells can phagocytoze, have a longer life span, are more resistance to apoptosis but migrate less efficiently than mature granulocytes (Drifte et al., 2013) .
However, neutrophil phenotypes do not merely reflect cellular aging and more functionally distinct phenotypes have also been described (Silvestre Roig et al., 2016) . Although our understanding of the nature of these phenotypes is incomplete, it appears that different phenotypes are present at different stages of the inflammatory process. In models of acute lung injury, there appear to be two waves of neutrophil recruitment; the first is the classical and pro-inflammatory neutrophil, as described above, which has been associated with significant tissue damage (Yang et al., 2003) . The second wave appears to be a pro-angiogenic neutrophil (Bekes et al., 2011) , which is found in hypoxic tissues, can be identified by being CD49d + VEGFR1 high CXCR4 high , is characterized by increased MMP-9 release (Christoffersson et al., 2012; Massena et al., 2015) and has been associated with improved clinical outcomes (Blázquez-Prieto et al., 2017). There are also descriptions of anti-inflammatory neutrophils including low-density neutrophils (LDN) that appear in transient inflammation and during tumor clearance (Sagiv Jitka et al., 2015) and neutrophils which appear to modulate T cell function via Mac 1 signaling, leading to immune suppression (Pillay et al., 2012) . Not all neutrophils stay in tissues for clearance by efferocytosis, and a subset have been shown to "reverse transmigrate" back into the systemic circulation (Buckley et al., 2006) . How neutrophil populations change to respond to environmental challenges is unclear and it is yet unknown whether any of these phenotypes represent "senescent" neutrophils but population plasticity is well recognized in T cells (Magombedze et al., 2013) and monocytes/macrophages (Das et al., 2015) and might also occur in neutrophils.
Neutrophils from the aging host
There are many theories of why we age as an organism but host and cellular aging appear inextricably linked. It has been hypothesized that host aging represents a failure of somatic maintenance, resulting in a build-up of cellular damage (Kirkwood, 2005) and most models of aging include an increased presence of senescent cells which have been linked to organ dysfunction, disease and poor host outcomes (Childs et al., 2015) . Even in health, the aging host represents a pro-inflammatory environment for immune cells, with greater circulating levels of a number of cytokines including IL-6, Tumor necrosis factor (TNF)α and IL-β (Franceschi and Campisi, 2014) which might impact on cellular functions.
In health, neutrophil numbers do not change as we age (Wenisch et al., 2000) , however, during severe infections, older patients can exhibit a neutropenia, due to the blunted response of neutrophil progenitors to granulocyte colony stimulating factor (G-CSF) with age, which in health is compensated for by Granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-3 (Chatta et al., 1993; Lord et al., 2001) . Furthermore, the ability to delay apoptosis in response to survival signals (GM-CSF, Interferon-1) at the site of inflammation is impaired (Fortin et al., 2007) and thus prolonged infectious insults can result in the double challenge of a reduction in mobilization of immature neutrophil from the bone marrow without an increase in the survival of activated, mature cells.
Neutrophils donated from an old host often show a functional decline. Neutrophil adhesion to the endothelium appears unaltered in an aging population (MacGregor and Shalit, 1990; Butcher et al., 2000) , suggesting that extravasation of neutrophils is unchanged in old age but chemotaxis appears impaired with age (Fulop et al., 2004; Niwa et al., 1989) . We have published evidence that neutrophils from older donors are less able to accurately migrate due to dysregulated and excessive PI3K activity and although there is a decline from middle age, the deficit is most apparent after people reach their sixth decade of life. This is associated with an increase in primary granule mobilization and increased neutrophil proteinase activity, as demonstrated by higher levels of CD63 on the surface of neutrophils and increased neutrophil elastase specific degradation products , supporting increased degranulation. There is a reduction in phagocytic ability for opsonized bacteria (Butcher et al., 2000; Butcher et al., 2001; Weiskopf et al., 2009 ), especially to Staphylococcus aureus (Wenisch et al., 2000) , an organism the elderly are notoriously susceptible to. CD16 levels are reduced with age, impacting Fc-mediated phagocytosis and Fc Receptor triggered oxidative burst (Fülöp et al., 1985) . This phagocytic deficit is not mirrored in unopsonized bacteria (Emanuelli et al., 1986) , suggesting the receptors of innate recognition (e.g. CD14) are not affected by aging (Weiskopf et al., 2009 ). Finally, NET release are reduced in cells isolated from old subjects, in response to a number of physiological and pathological stimuli including lipopolysaccharide (LPS) and interleukin-8 (IL-8) (Hazeldine et al., 2014) .
It is unclear why neutrophils from old donors have these functional deficits but it has been hypothesized that the low-grade inflammatory systemic environment seen with aging (Franceschi and Campisi, 2014; De Martinis et al., 2005) may lead to epigenetic changes in cells, such as DNA methylation (which has been shown to vary widely between individuals (Chatterjee et al., 2015) ) which in turn may impact on cellular phenotype and function (Chen et al., 2016) . These changes might alter the responses of immune cells to further inflammatory stimuli in a negative manner, heightening the potential for microbial invasion and host damage (Ecker et al., 2017) . Currently, this mechanism remains putative, demonstrated in a limited number of studies. Further studies, ideally longitudinal and therefore long-term, will be needed to firmly link epigenetic changes to alterations in cellular functions to clinical outcomes, but these will be challenging to perform.
The impact of disease on neutrophil functions with age
Should sustained inflammation be causally implicated in dysregulated neutrophil responses, one might predict that chronic inflammatory diseases would be associated with an even greater burden of cellular dysfunction compared to healthy aging, as they are associated with more inflammation. There is some evidence to support this theory.
Cardiovascular disease is associated with neutrophilic inflammation. Neutrophil recruitment is associated with impaired microvascular perfusion, left ventricular dilation and adverse cardiac events in patients treated for myocardial infarction (Takahashi et al., 2008) . Furthermore, myeloperoxidase (a marker of neutrophil activity) is increased acutely following myocardial damage and predicts outcomes (Takahashi et al., 2008; Kaya et al., 2012) . Similar to acute lung injury, there appear to be two waves of neutrophil recruitment to areas of infarction, with the first wave being pro-inflammatory, causing tissue damage (Litt et al., 1989) and the second being pro-angiogenic, assisting with new vessel formation and tissue reperfusion (Iyer et al., 2016) , perhaps reflecting two different phenotypes of neutrophils. In old adults, changes in the expression and function of neutrophil small GTPases (which act downstream to PI3K, already implicated in neutrophil dysfunction ) appear to favor tissue damage rather than repair, and are associated with an increased future risk of cardiovascular disease (Florian et al., 2017) . Accelerated epigenetic aging has been associated with cardiovascular risk (Horvath et al., 2016; Perna et al., 2016) , with hypermethylation of the gene body of Rho GTPase-activating protein 24 (ARHGAP24) reported in old patients with heart failure (Movassagh et al., 2010) and DNA methylation in peripheral blood leukocytes related to atherosclerosis in older adults (Castro et al., 2003) . Together, these studies support a link between accelerated aging, epigenetic influences, neutrophil functions and cardiovascular outcomes.
Similarly, neutrophils from patients with Chronic Obstructive Pulmonary Disease (COPD), which is classically characterized by neutrophilic inflammation (Stone et al., 2012) demonstrate some of the functional deficits present in the aging host. This includes poor migratory accuracy causally associated with PI3K signaling (Sapey et al., 2011 ) a pro-inflammatory phenotype (Loi et al., 2017) with evidence of increased degranulation (Carter et al., 2012) but crucially, these changes to neutrophil function appear at younger age than seen in healthy smoking controls (Sapey et al., 2011) . Smoking cigarettes, a pro-inflammatory pastime and the greatest risk factor for COPD, is associated with an accelerated epigenetic aging profile (DeMeo et al., 2016) which in turn is associated with the onset of chronic lung diseases including COPD and lung cancer (Levine et al., 2015) .
Most studies have only compared one chronic disease state to health and it is unclear whether multi-morbidity might alter neutrophil functions more than a single disease state. However, studies of other aspects of cellular immunity and inflammation provide some insights which suggest this might be the case. Data from the U.S. National Health and Nutrition Examination Survey data collected between 1999 and 2008 described relationships between C-reactive protein, white blood cell count, segmented neutrophils percent, eosinophils percent and glycohemoglobin levels and the number of chronic diseases present in an individual (Stepanova et al., 2015) .
The role of infections
Severe infections are associated with an even greater burden of inflammation than chronic diseases, albeit (usually) over a shorter period of time and one might see changes in cellular phenotypes after these infective events.
A number of studies have highlighted the increased inflammatory burden experienced by older people during an infection. Systemic proinflammatory cytokines and chemokines including (for example) CXCL8, TNFα, IL-1β and IL-6 have been shown to be increased in a sustained manner during episodes of severe infections and sepsis in old adults compared to younger adults experiencing similar infective events (Ginde et al., 2014; Inoue et al., 2014) .
Despite this pro-inflammatory state during infections, cross sectional data suggest that the immune response is impaired, leading to a paradoxical state of enhanced systemic inflammation but also reduced immune capacity. There is a stepwise decrease in the effectiveness of the immune response and in particular the accuracy of neutrophil migration, as the severity of the infectious insult progresses in old patients (from a simple lung infection to pneumonia with sepsis), but this is not seen in young adults until the development of sepsis . Of interest, the highly blunted neutrophil responses described in sepsis (Arraes et al., 2006) and implicated in multi-organ failure (Brown et al., 2006) occur in both young and old adults, and are associated with sustained inflammation (Arraes et al., 2006) with a reduction in antiinflammatory signaling (Kellum et al., 2007) . Neutrophil functions remain blunted at six weeks following the infective event, suggesting a prolonged period of immune suppression, but of note, this is only seen in old adults, as neutrophils from young donors recover to baseline functions within this time . In support of this experimental finding, primary infections are often followed by secondary infections in old adults, associated with immune suppression and poorer clinical outcomes (van Vught et al., 2016) .
Most studies of cell functions during infection have not considered multi-morbidity, but it is clear that patients with multiple co-morbidities have the worse clinical outcomes. Therefore, it is tempting to hypothesize that neutrophil functions may be further impaired.
In summary, current data support a similar alteration of neutrophil functions in a number of chronic inflammatory diseases and during infections in old age. Inflammation and epigenetic modifications are noted in some studies, and therefore might represent a shared mechanism of effect. However, current data is not prospective, and therefore it is unclear which came first; the aging, the altered neutrophil function, the illness (be that the chronic disease or severe infective event), the inflammation or the epigenetic change. It is also uncertain why neutrophil responses change with age and illness.
Neutrophils do not act in isolation, but represent a component of a (usually) highly coordinated immune response, and just as there is evidence of dysregulated neutrophil responses with age and disease, similar defects have been described with other cells of the immune system. For example, monocyte and macrophage function has been shown to be altered with age (Prattichizzo et al., 2016) , and in chronic disease such as COPD (Taylor et al., 2010) where a reduction in antiaging molecules has been described (Baker et al., 2016) .
In some age-related chronic diseases, a reduction in the plasticity of immune cell populations has been described, which might favor sustained inflammation. For example, in Rheumatoid arthritis, this has been described within joint T cell populations (Wang et al., 2015) and in COPD, monocyte derived macrophages have been shown to retain a pro-inflammatory profile; losing their ability to change to an anti-inflammatory phenotype, in contrast with cells isolated from non-COPD controls (Chana et al., 2012) . With aging, there might be epigeneticdriven changes in either the proportion of different phenotypic populations of neutrophils, or an inability to change phenotype during specific challenges. Chronic disease and severe infections might amplify these responses, creating a negative cycle of further cellular dysfunction (see Fig. 2 ). If this were the case, it is likely that all facets of the immune system would be affected and indeed, there is significant evidence to support the notion that this is not a "one cell" problem.
Targeted treatments
Further work is needed to understand the mechanisms underpinning the decline in the immune system with age, but already some potential targets have been identified which may offer therapeutic relief by targeting immune responses.
PI3K has been implicated in the neutrophil migratory defect seen with aging, and PI3K inhibitors have been shown to restore neutrophil migratory accuracy in vitro, especially Class 1 delta and gamma isoforms which are enriched in neutrophils and implicated in cell migration. Early phase clinical trials of a PI3K delta inhibitor to improve inflammation are already underway in COPD and bronchiectasis, a suppurative lung disease (Doukas et al., 2009) .
Nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf2) has been shown to be decreased in a number of aging co-morbidities including COPD (Ito et al., 2012) . Low levels of Nrf2 would contribute to oxidative stress, and pharmacological activation of Nrf2 by sulforaphane, a potent activator of Nrf2, has been shown to improve facets of the immune response in innate immune cells, including enhancing the phagocytosis of bacteria (Harvey et al., 2010) .
If mechanisms are linked by the common theme of aging in multimorbidity, therapeutic targets could cross disease silos. Recently, we have shown that 80 mg Simvastatin (a HMG Co-A reductase inhibitor classically used to reduce cholesterol levels) once daily for two weeks restored neutrophil migratory accuracy in a randomised, doubleblinded clinical trial in healthy old adults. The same dose had the same restorative effect on neutrophil migration during pneumonia but not sepsis and not in young adults in vitro . This builds on a body of evidence suggesting that statins may positively impact on patient outcomes during infections, but only when used in old adults, at high dose, and before the onset of severe sepsis (Patel et al., 2013) . The exact mechanism of effect is unclear, but statins are known to alter small GTPase activity, which in turn would impact on cellular polarity and migrational accuracy (Maher et al., 2009 ). We have also reported similar positive effects on immune function when statins were used in COPD (Walton et al., 2016) and there are on-going studies of statins being used in inflammatory conditions far removed from cholesterol modification, including uveitis (Gilbert et al., 2017) , where neutrophils are implicated in tissue damage (Sonoda et al., 2011) .
There is great interest in the development of drugs to maintain healthy aging, and this is an area of pharmacodiscovery which needs to expand.
Conclusion
Multi-morbidity and the sequelae of surviving severe infections are associated with a significant burden of ill health in old adults. Many of these conditions share a sustained and damaging inflammatory response with innate immunity, and in particular neutrophils, implicated in disease processes. There is increasing evidence to support a global decline in immune cell function in old age, which appears even more compromised in the presence of inflammatory challenges such as chronic disease and acute infections. Recent studies of neutrophils in (mainly murine) disease models support there being different phenotypes of neutrophils, which present to tissues depending on the inflammatory challenge. In some studies, these cells have been termed "senescent". Being a non-dividing cell, it is unclear whether neutrophils can enter a senescent state, as described in other cells, and whether they can remain pro-inflammatory without entering apoptosis or being cleared by macrophages. More studies are needed to understand neutrophil responses and phenotypes in age, disease and multi-morbidity, but emerging evidence suggest that we can target these processes, and this may give us new therapeutic options to improve older patient outcomes.
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